Myeloma recurrence: treatments, associated drugs and conditions

Summary:

Myeloma recurrence: recurrence of cancer of the plasma cells - a kind of white blood cell.

We study 580 people who have Myeloma recurrence. The information that eHealthMe analyzes includes:

- Medications that treat Myeloma recurrence and their effectiveness
- 176 drugs that are associated with Myeloma recurrence



Number of reports submitted per year:

Myeloma recurrence: 580 reports.

All the drugs that are associated with Myeloma recurrence:

Do you take any medication?

- You can use our AI-powered tools to monitor drug safety and effectiveness.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.



Recent studies on eHealthMe: